Literature DB >> 28263803

Prostaglandin E2 regulates renal function in C57/BL6 mouse with 5/6 nephrectomy.

J Jin1, Q Tang2, Z Li1, Z Zhao3, Z Zhang3, L Lu4, T Zhu2, P M Vanhoutte5, S W Leung5, R Tu6, Y Shi7.   

Abstract

AIMS: To investigate the roles of cyclooxygenases (COX) and their metabolites in C57/BL6 mice with 5/6 nephrectomy, an animal model of chronic renal failure. MAIN
METHODS: C57/BL6 mice were grouped into sham-operated (2K), one kidney removal (1K) and 5/6 nephrectomy groups (5/6Nx). Renal resistive index was measured by ultrasonography. Blood, aortae, renal arteries and renal cortex were collected for measurement of kidney function, assessment of vascular responsiveness, Western blotting, immuohistochemistry and enzyme-linked immunosorbent assays. KEY
FINDINGS: After four weeks, acetylcholine-induced relaxations were blunted in renal arteries of 1K and 5/6Nx mice; indomethacin, a non-selective COX inhibitor, improved the response in 5/6Nx, but not in 1K renal arteries. In 5/6Nx renal arteries, but not in 1K preparations, the protein presence of endothelial nitric oxide synthase (eNOS) was decreased, while that of COX-2 and its products [prostacyclin and thromboxane A2] were increased. The renal resistive index was lower in 5/6Nx mice, suggesting a lower resistance in the renal microvasculature. In the renal cortex of 5/6Nx mice, eNOS protein presence was increased; while the presence of COX-2 was not detectable. The prostaglandin E2 level was lower in the 5/6Nx cortex than in the other two groups. SIGNIFICANCE: The early stage of renal mass removal is associated with increased renal arterial constriction and reduced microvascular resistance. The former is due to downregulation of eNOS and upregulation of COX-2, leading to an increased production of prostacyclin and thromboxane A2. A reduced production of PGE2 in the renal cortex is important for maintaining normal renal function.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  5/6 nephrectomy; Cyclooxygenases; Endothelial nitric oxide synthase; Prostaglandin E(2); Prostanoids; Renal function

Mesh:

Substances:

Year:  2017        PMID: 28263803     DOI: 10.1016/j.lfs.2017.03.001

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.

Authors:  Ehécatl Miguel Ángel García Trejo; Abraham Said Arellano Buendía; Omegar Sánchez Reyes; Fernando Enrique García Arroyo; Raúl Arguello García; María Lilia Loredo Mendoza; Edilia Tapia; Laura Gabriela Sánchez Lozada; Horacio Osorio Alonso
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

2.  PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis.

Authors:  Wenhao Jiang; Yunyun Jin; Shiwei Zhang; Yi Ding; Konglin Huo; Junjie Yang; Lei Zhao; Baoning Nian; Tao P Zhong; Weiqiang Lu; Hankun Zhang; Xu Cao; Karan Mehul Shah; Ning Wang; Mingyao Liu; Jian Luo
Journal:  Bone Res       Date:  2022-03-09       Impact factor: 13.362

Review 3.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29

4.  Major histocompatibility complexes are up-regulated in glomerular endothelial cells via activation of c-Jun N-terminal kinase in 5/6 nephrectomy mice.

Authors:  Dong Zhu; Qunye Tang; Baixue Yu; Mei Meng; Wenjie Liu; Jiawei Li; Tongyu Zhu; Paul M Vanhoutte; Susan W S Leung; Yi Zhang; Yi Shi
Journal:  Br J Pharmacol       Date:  2020-09-30       Impact factor: 8.739

Review 5.  The glycolytic process in endothelial cells and its implications.

Authors:  Susan Wai Sum Leung; Yi Shi
Journal:  Acta Pharmacol Sin       Date:  2021-04-13       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.